Cocaine consumption and demands for treatment have increased in Europe in recent years. On average, in Europe 14 million Europeans have used it at least once in their life, (4.1 % of adults aged 15-64 years) and 4 million Europeans have used the drug in the last year (1.3 %), being Spain the leading European country in the consumption of cocaine (1). The US National Comorbidity Survey found that 3.8% of the general population has a substance use disorder, and 65% of drug dependent individuals develop at least one mental disorder throughout their lifetime (2, 3) . Chronic consumption of cocaine can induce transient psychotic symptoms, expressed as paranoia or hallucinations. The term cocaine induced psychosis (CIP) has been used to describe this syndrome. These symptoms disappear typically with abstinence (4) (5) (6) (7) (8) .
Associating these symptoms with a DSM-IV diagnostic category is a complex process.
CIP symptoms can appear with cocaine intoxication and they can also be present in psychotic disorders induced by cocaine. These diagnostic criteria are controversial and have been the subject of some criticism (9) . Assessment of psychotic symptoms induced or exacerbated by cocaine in patients with chronic psychotic disorders such as schizophrenia or bipolar disorder is difficult because such patients often lack insight into their psychotic symptoms, whether or not they are cocaine-related. In contrast, cocaine users without chronic psychotic disorders, but who report CIP, almost always have retrospective insight into the distorted nature of their experiences during cocaine intoxication, even though they often lack such insight while intoxicated.
Besides the risks associated with CIP symptoms, some studies have observed that drug dependent-individuals with cocaine induced paranoia are at higher risk of developing a psychotic disorder (4, 10) . CIP prevalence is not exactly known; different studies have reported prevalences between 48% and 88% (11) (12) (13) . The wide range of prevalences found are probably due to the variability and bias in the samples studied, the different study designs, instruments used for assessment, and administration routes used.
As for the clinical factors that moderate the appearance of CIP, several factors have been found that increase the possibility of a CIP. Several researches agree with the idea that the amount of cocaine consumed both in laboratory and clinical studies (8, (14) (15) (16) (17) and early-onset of cocaine use (6, 12, 14) are positively related to CIP. It has also been reported that the early-onset of cocaine dependence, or in vulnerable periods of brain development, may lead to increase the severity of CIP (14, 18) . However, it has been found that the number of years of cocaine use does not correlate with cocaine-induced psychosis (19) . It has also been established that different routes of administration from the nasal airway like smoking (15) or intravenous use (17) may increase the risk of CIP.
Comorbidity with other substance use disorders, such as cannabis use seems to play a mediating role for developing psychotic symptoms. Tang et al. observed a statistically significant difference in the frequency of CIP in cocaine dependent individuals based on cannabis dependence, but this difference did not remain statistically significant after adjusting for age and sex (7). Kalayasiri et al. recently found that adolescent-onset of cannabis use increases the risk of CIP in cocaine dependent individuals (12) .
CIP can be linked to hostile behaviours and antisocial personality disorder (ASPD). A pattern in which the stimulants generate hostility through psychotic symptoms has been suggested. This contributes to a perception of the environment as a hostile and threatening place, as well as through increasing impulsivity, thus CIP can trigger hostile behaviours (7, 20) .
Although the assessment of traits and personality disorders during heavy drug use is complex and there is debate about its stability (21, 22) , comorbid Axis II disorders are especially prevalent in cocaine users. Several studies found prevalences of personality disorders ranging from 30 to 77% in inpatient or outpatient samples (10), being antisocial and borderline personality disorders, the most prevalent (23). Kranzler et al. compared the frequency of CIP in patients with and without personality disorders but did not find significant differences (10). However, it is possible that antisocial personality traits are related with CIP. Recently, Tang identified that cocaine-dependent patients who experienced CIP tend to present a comorbid ASPD more frequently (7) .
Despite this, the relationship between personality disorders and psychotic symptoms induced by cocaine, are clearly not sufficiently analysed.
This study examined the relationship between CIP and substance consumption variables and personality disorders, and attempted to identify risk factors for CIP. Although other studies have been published on this topic, this is the first to study both substance consumption and personality disorders simultaneously in a European clinical sample.
Subjects and Methods

Procedure
We performed a cross-sectional, observational study. The participants were patients of the Psychiatric Department of the Vall d'Hebron Hospital (Barcelona, Spain).
Specifically, they were cocaine-dependent patients treated in a Substance Use Disorders Unit, who began treatment between January 2006 and December 2008. This study is part of a more extensive research on the comorbidity in cocaine dependence.
Inclusion criteria were: age over 18, cocaine dependence according to DSM-IV criteria, and signing the informed consent prior to participation. Exclusion criteria were: psychotic disorder or bipolar type I disorder, intoxication at baseline examination, severe somatic disease at baseline examination and low language proficiency. We excluded psychotic and bipolar patients in order to avoid the risk of not being able to distinguish primary and secondary symptomatology. However, its known that CIP can be measured in psychotic patients (24) 
Participants
From a total of 238 patients who contacted our unit, 173 finally took part in the study.
The flow chart of the study is presented in Figure 1 . 
Severity of substance use disorder. The Spanish version of the European
Addiction Severity Index (EuropASI) was used (25) . This is a face-to-face structured interview which measures several domains: general medical information, alcohol and drug use, employment and support, family and social relationships, legal status and psychiatric status. The EuropASI is an adaptation of the fifth version of the Addiction Severity Index (26, 27) . It is one of the most widely used assessment and diagnostic tools in Europe.
Variables related with cocaine consumption. Amount of cocaine consumed per
week, years of cocaine dependence and main cocaine route of administration at the beginning of the treatment were systematically registered.
Substance Use Disorders.
The Structured Clinical Interview for DSM IV Axis I disorders (SCID I) was used in order to identify substance use disorders (28). This tool is widely used and it has shown good psychometric properties (29).
Personality Disorders. The Structured Clinical Interview for DSM IV Axis II
Personality Disorders (SCID II) was used to evaluate this topic. This tool has shown adequate reliability and usefulness in providing fine discriminations between Axis II disorders (30) . The Spanish translation has an overall kappa of 0.85(31).
Data Analysis
Data analysis was performed in three steps: descriptive, bivariate and multivariate analyses. The first step includes the description of all variables in terms of percentages, means and standard deviations. These variables were clustered in four groups: a) demographic variables, including gender, age, educational level and nationality, b) cocaine consumption pattern, including weekly amount of cocaine consumed, years of cocaine dependence and main cocaine route of administration c) lifetime substance use disorders, including cannabis, opioids, benzodiazepines, alcohol and tobacco dependence, and d) personality disorders (Antisocial Personality Disorder and Borderline Personality Disorder). The second step consisted in analyzing bivariate associations between each variable described above and CIP. The Kolmogorov-Smirnov test was used as a measure of normality. In this context, Mann-Whitney U and Chisquare tests were performed. In order to reduce the presence of some false positive effects, different Bonferroni corrections for multiple tests were performed. The magnitude of each correction was a function of the number of variables in each of the four clusters of variables described above. Consequently, demographic variables were only considered significant with a P value less than .013 (.05/4). Variables included in the cocaine consumption pattern had a reference P value of .017 (amount of cocaine consumed per week, route of cocaine consumption, and years of cocaine dependence).
In the case of the variables included in the substance dependences (cannabis, opioids, benzodiazepines, alcohol and tobacco) cluster the p value was .01 (.05/5) and in the case of personality disorders the P value was .025 (.05/2). Only the variables that exceeded the respective P values participated in the second analysis. In this step these variables were used in a multivariate logistic regression analysis as predictors, using backward conditional entry in order to perform an exploratory analysis including CIP as a dependent variable. In order to provide information on the adjustment of the resulting model, sensitivity (capacity to detect CIP subjects) and specificity (capacity to detect non CIP subjects) parameters were reported. Subsequently, in order to identify a symptomatic pattern, relations of psychotic symptoms with independent variables included in the model were analysed using bivariate statistics. All statistical hypotheses were two-tailed. SPSS, version 18.0 for Windows was used for all analyses.
Results
Descriptive information
A shown in Table 1 , most of the participants were young Spanish males and with primary school studies. The European Severity Index scores showed that employment status, family relationship and psychiatric status were the most affected domains. 
Substance Use Disorders
As can be seen in Table 2 , we found that cocaine dependent patients with CIP tend to be cannabis and tobacco dependent throughout their lives more often than patients without CIP. From this group, only lifetime cannabis dependence remains statistically significant after Bonferroni correction. 
Axis II
As shown in Table 2 , Borderline Personality Disorder (BPD) and ASPD were the most prevalent. Only these showed a rate that allowed their statistical significance to be tested. When comparing patients with and without CIP, we found that both BPD and ASPD are associated with psychotic symptoms in consumption contexts. From this group, only antisocial personality disorder remains statistically significant after Bonferroni correction.
Multivariate analysis
A backward conditional logistic regression analysis was carried out in order to analyze all variables from the previous bivariate analysis that remained statistically significant after Bonferroni correction. These variables were: cocaine grams/week, antisocial personality disorder, lifetime cannabis dependence, and route of administration (we grouped this variable in intranasal versus the rest of routes due to the fact that associated, we decided to take all in account for the analysis due to its conceptual independence, but using conditional entry with the objective of discarding variables with low explicative capacity.
Amount of cocaine and ASPD were significant in both models. Lifetime cannabis dependence had only a statistical tendency using a standard cut point of .05 (the standard criteria of non-inclusion in conditional models is .1). However, according to the literature, cannabis dependence could contribute to psychotic symptomatology (12, 34, 35 
Discussion
The present research examines the relationship of cocaine-induced psychosis with consumption patterns and personality disorders in cocaine dependent patients. The results shown that CIP is very common in cocaine-dependent patients who seek treatment, and particularly in patients who consume higher doses of cocaine, diagnosed with antisocial personality disorder and cannabis dependence throughout their lives.
Although our objective was not to identify the prevalence of CIP, these results show a frequency of several psychotic symptoms reported by cocaine-dependent patients in a general hospital sample. Although these symptoms were communicated by more than half of the patients seeking treatment, our study reports a relatively low rate of CIP probably because we failed to take in account behavioural symptoms. However, it has been hypothesized that the appearance of CIP in the first contacts with cocaine is associated with a lower risk of developing cocaine addiction (36) . The most often reported psychotic symptoms were paranoid beliefs and suspiciousness. These results are consistent with results from previous investigations, which found frequencies between 48% and 88% (4, 6, 7, 11, 18) .
We also found that the amount of cocaine consumed at the beginning of treatment is a risk factor for CIP, consistently with data from retrospective reports and laboratory studies (8, 14, 16, 17) . It has been reported that the substance use disorder severity is associated with the prevalence of psychotic symptoms, and that the prevalence of CIP is higher in dependent individuals than in abusers of cocaine (11), and in the most severely dependent patients (11, 12) . One explanation for this finding could be related to the common pathways between cocaine mechanisms of action and psychosis neurobiology.
Cocaine is believed to produce psychotic symptoms by increasing cortical and subcortical dopamine levels, and it is possible to identify an increased synaptic dopamine level both in the cocaine effects and in the positive psychotic symptoms ( suggests that there may be some common vulnerability factors that contribute to both cocaine-induced psychosis and aggressive behaviours (13) . It can be based on a dysfunction in the dopaminergic receptors (6, (39) (40) (41) . On the other hand anti-social individuals may be more likely to place themselves in dangerous or anxiety-provoking situations, leading to greater paranoia and visual and auditory hallucinations as well as be more likely to be cannabis dependent as our results show. However, these hypotheses should be studied more in depth.
The high prevalence of cannabis use in primary cocaine-users is known to be around50-70% (42, 43), or cocaine-dependent patients (35.4%) (13) . A strong association between heavy cannabis use and the development of schizophrenia-spectrum psychoses has been described (44, 45 an earlier onset of cannabis use in patients with CIP than those without (12) . Therefore, we conclude that high cannabis use could be related to CIP; understood as two situations, either an early-onset of use, or the development of cannabis dependence. It is possible that, there are common mechanisms within this association for the development of psychotic symptoms, such as neurobiological pathways that increase the risk of CIP. In the same study, the catechol-O-methyl-transferase (COMT) gene was studied but no interaction was found with early cannabis onset (12) .
As limitations of the study, the self-reporting nature of the data must be considered. We evaluated cocaine-dependent patients who were seeking treatment and therefore, these results cannot be generalized to other cocaine-user populations. Cocaine amount used in consumption episodes with psychotic symptoms was not evaluated, for that reason the dose-effect relationship cannot be studied. We can only associate CIP with higher consumption at treatment onset. Another limitation is that symptom severity was not controlled, and our patients were not able to refer symptoms duration and intervention needed.
As strengths of the study, we believe that the multivariate analysis including consumption pattern variables and personality disorders is noteworthy. We offered a new model integrating previous knowledge: amount of cocaine consumption, presence of ASPD and cannabis lifetime dependence had a proper sensitivity and specificity to predict the presence of CIP. Furthermore, most previous studies have been performed with American population samples. This study has been carried out in Europe and could be considered relevant, due to the different consumption patterns present in this region, e.g. crack cocaine consumption is not still widespread in Europe (47) .
Finally, we consider that professionals who work with cocaine dependent-patients should incorporate these considerations into an integral approach. As CIP is very common in this population, clinicians should be especially attentive and explore it in patients who consume high quantities of cocaine, diagnosed of Antisocial Personality
Disorder and/or cannabis dependence history. Identifying these types of symptoms can be useful to minimize the presence and risks during psychotic states.
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